Vimseltinib becomes first authorised therapy for tenosynovial giant cell tumour in the EU
Month: September 2025
Preclinical results highlight potential of glycosaminoglycan-based therapy
bmj;390/sep18_1/r1921/FAF1fa“To fully understand our patients, we ideally need to have shared experience with them,” paediatric trainee Sophie Jackson […]
Mahase quotes her colleague’s experience at work related to their hearing impairment.1 The story is very similar to […]
bmj;390/sep17_1/r1946/FAF1faDavid Isaacs was considered the father of paediatric infectious diseases in Australia and New Zealand12 but he is […]
Doctors refusing to use “untried and untested” artificial intelligence (AI) software at work will be supported by the […]
The arrival of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide marks an important moment […]
Contradictory statements suggesting the US incinerated $9.7m (£7.4m; €8.4m) worth of contraceptives intended mostly for low income countries […]
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT